BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 35576953)

  • 21. Prevalence of hepatitis B and hepatitis C virus co-infection in India: A systematic review and meta-analysis.
    Desikan P; Khan Z
    Indian J Med Microbiol; 2017; 35(3):332-339. PubMed ID: 29063876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of occult hepatitis B virus infection in adults: a systematic review and meta-analysis.
    Im YR; Jagdish R; Leith D; Kim JU; Yoshida K; Majid A; Ge Y; Ndow G; Shimakawa Y; Lemoine M
    Lancet Gastroenterol Hepatol; 2022 Oct; 7(10):932-942. PubMed ID: 35961359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sero-epidemiology and associated factors of HIV, HBV, HCV and syphilis among blood donors in Ethiopia: a systematic review and meta-analysis.
    Melku M; Ambachew S; Enawgaw B; Abebe M; Abebe Z; Deressa T; Damtie D; Biadgo B; Tessema B; Geremew D; Kebede A; Woldu B; Teklu T; Shiferaw E
    BMC Infect Dis; 2021 Aug; 21(1):778. PubMed ID: 34372772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology of hepatitis B, C and D in Malawi: systematic review.
    Stockdale AJ; Mitambo C; Everett D; Geretti AM; Gordon MA
    BMC Infect Dis; 2018 Oct; 18(1):516. PubMed ID: 30314448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis C virus, alcoholic cirrhosis, and hepatocellular carcinoma.
    Goeser T; Müller HM; Solbach C; Toex U; Kommerell B; Theilmann L
    Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):311-5. PubMed ID: 8061579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics of patients with hepatitis B virus and hepatitis C virus dual infection in a Western European country: Comparison with monoinfected patients.
    Marot A; Belaid A; Orlent H; Sersté T; Michielsen P; Colle I; Laleman W; de Galocsy C; Reynaert H; D'Heygere F; Moreno C; Doerig C; Henrion J; Deltenre P
    Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):656-663. PubMed ID: 28867077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of injecting drug use and HIV, hepatitis B, and hepatitis C in people who inject drugs in the Eastern Mediterranean region: a systematic review and meta-analysis.
    Aghaei AM; Gholami J; Sangchooli A; Rostam-Abadi Y; Olamazadeh S; Ardeshir M; Baheshmat S; Shadloo B; Taj M; Saeed K; Rahimi-Movaghar A
    Lancet Glob Health; 2023 Aug; 11(8):e1225-e1237. PubMed ID: 37474230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prevalence and associated factors of hepatitis B and C virus in hemodialysis patients in Africa: A systematic review and meta-analysis.
    Adane T; Getawa S
    PLoS One; 2021; 16(6):e0251570. PubMed ID: 34157037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations between the prevalence of chronic hepatitis B among people who inject drugs and country-level characteristics: An ecological analysis.
    Syangbo A; Hickman M; Colledge-Frisby S; Leung J; Grebely J; Larney S; Degenhardt L; Trickey A
    Drug Alcohol Rev; 2023 Mar; 42(3):569-581. PubMed ID: 36600489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seroprevalence of hepatitis B virus and hepatitis C virus co-infection among people living with HIV/AIDS visiting antiretroviral therapy centres in Nepal: a first nationally representative study.
    Ionita G; Malviya A; Rajbhandari R; Schluter WW; Sharma G; Kakchapati S; Rijal S; Dixit S
    Int J Infect Dis; 2017 Jul; 60():64-69. PubMed ID: 28483724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis B and C virus infections in hepatocellular carcinoma and cirrhosis in Mongolia.
    Dondog B; Lise M; Dondov O; Baldandorj B; Franceschi S
    Eur J Cancer Prev; 2011 Jan; 20(1):33-9. PubMed ID: 21166097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different impacts of common risk factors associated with thrombocytopenia in patients with hepatitis B virus and hepatitis C virus infection.
    Huang CE; Chang JJ; Wu YY; Huang SH; Chen WM; Hsu CC; Lu CH; Hung CH; Shi CS; Lee KD; Chen CC; Chen MC
    Biomed J; 2022 Oct; 45(5):788-797. PubMed ID: 34508913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*.
    Hatzakis A; Wait S; Bruix J; Buti M; Carballo M; Cavaleri M; Colombo M; Delarocque-Astagneau E; Dusheiko G; Esmat G; Esteban R; Goldberg D; Gore C; Lok AS; Manns M; Marcellin P; Papatheodoridis G; Peterle A; Prati D; Piorkowsky N; Rizzetto M; Roudot-Thoraval F; Soriano V; Thomas HC; Thursz M; Valla D; van Damme P; Veldhuijzen IK; Wedemeyer H; Wiessing L; Zanetti AR; Janssen HL
    J Viral Hepat; 2011 Sep; 18 Suppl 1():1-16. PubMed ID: 21824223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Global trends and the impact of chronic hepatitis B and C on disability-adjusted life years.
    Veracruz N; Gish RG; Cheung R; Chitnis AS; Wong RJ
    Liver Int; 2022 Oct; 42(10):2145-2153. PubMed ID: 35753064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
    Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
    BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV, hepatitis B & C in people who inject drugs in India: A systematic review of regional heterogeneity & overview of opioid substitution treatment.
    Shukla L; Shivaprakash P; Kumar MS
    Indian J Med Res; 2023 Nov; 158(5&6):522-534. PubMed ID: 38265946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aiming for the elimination of viral hepatitis in Australia, New Zealand, and the Pacific Islands and Territories: Where are we now and barriers to meeting World Health Organization targets by 2030.
    Howell J; Pedrana A; Cowie BC; Doyle J; Getahun A; Ward J; Gane E; Cunningham C; Wallace J; Lee A; Malani J; Thompson A; Hellard ME
    J Gastroenterol Hepatol; 2019 Jan; 34(1):40-48. PubMed ID: 30151932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology of HBV-HCV Coinfection Among Iranian Patients: a Systematic Review and Meta-Analysis.
    Anvari HZ; Binabaj MM; Asadi A; Abdi M; Shakiba A; Heidary M; Sholeh M
    Clin Lab; 2023 Nov; 69(11):. PubMed ID: 37948496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progress toward prevention of transfusion-transmitted hepatitis B and hepatitis C infection--sub-Saharan Africa, 2000-2011.
    Apata IW; Averhoff F; Pitman J; Bjork A; Yu J; Amin NA; Dhingra N; Kolwaite A; Marfin A;
    MMWR Morb Mortal Wkly Rep; 2014 Jul; 63(29):613-9. PubMed ID: 25055184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of Hepatitis B and Hepatitis C Viral Infections and Their Associated Factors among Diabetic Patients Visiting Debre Tabor Referral Hospital, Northwest Ethiopia, 2021: A Cross-Sectional Study.
    Belete D; Kassaw D; Andualem T
    Can J Gastroenterol Hepatol; 2023; 2023():5077706. PubMed ID: 38021268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.